New Link Established Between a Molecular Driver of Melanoma Progression and Novel Therapeutic Agent

Wistar scientists have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.